Based on comparisons using standard methylation-specific PCR and immunohistochemical studies using the anti-MGMT antibody, we determined 14% as the threshold distinguishing unmethylation from methylation of the MGMT promoter in a given tumor, as reported previously [26]. This evidence concerns the gene MGMT and neoplasm.